Summary
Seventy-five patients harboring astrocytomas received 4 cycles of infra-ophtalmic carotid injections of BCNU, combined with vincristine intravenously and procarbazine orally. All of the patients thereafter, received radiation therapy. The five year survival was 73% for all patients. The age of the patients had no significant impact on survival.
The treatment results were compared with the results of 57 patients with astrocytomas who were treated with surgery followed by radiation in the same period. These 57 patients had a 5 year survival of 45% with a five year survival in patients >- 40 years and patients < 40 years of 70% and 22%, respectively (p < 0.05).
In multivariate survival analysis of the BCNU group and radiation group together, treatment group and corticosteroid dependency were the only prognostic factors. No leukoencephalopathy was seen during the treatment or in the follow-up of the patients.
We conclude that pre-radiation infra-arterial chemotherapy can be given without significant morbidity and produces an improvement in survival in patients older than 40 years.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Russell DS, Rubinstein LJ: Pathology of tumours of nervous system. 3rd edition. Edward Arnold, London, 1971
Schoenberg BS: Epidemiology of primary nervous system neoplasms. In: Schoenberg BS (ed) Advances in neurology, Vol 19, Raven Press, New York 475–495, 1978
Marsa GW, Goffinet DR, Rubinstein LJ, Bagshaw MA: Megavoltage irradiation in the treatment of gliomas of the brain and spinal cord. Cancer 36: 1681–1689, 1975
Scanlon PW, Taylor WF: Radiotherapy of intracranial astrocytomas: analysis of 417 cases treated from 1960 through 1969. Neurosurg 5: 301–308, 1979
Clinton KL: Low grade astrocytomas: treatment results and prognostic variables. Int J Radiat Oncol Biol Phys 15: 837–841,1988
Laws ER, Taylor WF, Chifton MB, Okazaki H: Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg 61: 665–673, 1984
Leibel SA, Sheline GE, Wara WM et al.: The role of radiation therapy in the treatment of astrocytomas. Cancer 1975;35:1551–1557
Lindgren M: Roentgen treatment of gliomata. Acta Radiol 40: 325–334, 1953. Schulz MD, Wang CC, Zinninger GF et al.: Radiotherapy of intracranial neoplasms. Prog Neurol Surg 2: 318–370, 1968
Svien H, Mabon R, Kernohan JW: Astrocytomas. Mayo Clin Proc 25: 54–64, 1949
Leibel SA, Sheline GE: Radiation therapy for neoplasms of the brain. J Neurosurg 66: 1–22, 1987
Morantz RA: Radiation therapy in the treatment of cerebral astrocytoma. Neurosurg 20: 975–982, 1987
Bloom HJG: Intracranial tumors: Response and resistance to therapeutic endeavors. 1970–1980. Int J Radiat Oncol Biol Phys 8: 1083–1113, 1982
Fazekas JT: Treatment of Grades I and 11 brain astrocytomas. The role of radiotherapy. Int J Radiat Oncol Biol Phys 2:661–666,1977
Soffietti R, Adriano C: Prognostic factors in astrocytomas. Neurosurg 24 (5): 686–692, 1989
Sheline GE: Radiation therapy of brain tumors. Cancer 39: 873–881,1977
Avellanosa AM, West CR, Barua NR: Treatment of malignant CNS glioma by intra-arterial BCNU infusion. Proc Am Assoc Cancer Res 20: 384, 1979
Greenbert HS, Ensminger WD, Chandler WF: Intra-arterial BCNU chemotherapy for the treatment of malignant gliomas of the central nervous system. J Neurosurg 61: 423–429,1984
West CR, Avellanosa AM, Barua NR: Intra-arterial 1,3bis(2-chloroethyl)-1-nitrosourea (BCNU) and systemic chemotherapy for malignant gliomas: A follow-up study. Neurosurg 13: 420–426, 1983
Bigner DD, Bullard D, Schold C, Preissig SH, Wikstrand CJ: Cellular heterogeneity and diversity as a basis for therapeutic resistance of human gliomas. In: Paoletti P, Walker MD, Butti G, Knerich R (eds) Multidisciplinary aspects of brain tumor therapy, Elsevier/North-Holland, Amsterdam 329–335,1979
Bugdahn U: Chemosensitivity of malignant human brain tumors. J Neurol Oncol 1: 149–166, 1983
Edwards MS, Levin VA, Wilson CB: Brain tumor chemotherapy. Can Treat Rep 64: 1179–1205, 1980
Cox DR: Regression models and life-tables. JR Stat Soc B 34:187–220,1972
Cutler S, Ederer F: Maximum utilization of the life method in analyzing survival. J Chron Dis 8: 699–712, 1958
Dixon WJ, Brown MB, Engelman L (eds): BMDP Statistical Software Manual. University of California Press, Berkeley, 1988
Peto R, Pike MC, Armitage P: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 35: 1–39, 1977
Arnold DL, Shoubridge EA, Feindel W, Villemure JG: Metabolic changes in cerebral gliomas within hours of treatment with intra-arterial BCNU demonstrated by phosphorus magnetic resonance spectroscopy. Can J Neurol Sci 14: 570–575,1987
Lasker P, Ayres JW: Degradation of carmustine in aqueous media. J Pharmac Sci 66: 1073–1076, 1977
Wike-Hooley JL, Haveman J, Reinhold HS: The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol 2: 343–366, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Watne, K., Hannisdal, E., Nome, O. et al. Combined intra-arterial chemotherapy followed by radiation in astrocytomas. J Neuro-Oncol 14, 73–80 (1992). https://doi.org/10.1007/BF00170947
Issue Date:
DOI: https://doi.org/10.1007/BF00170947